MILWAUKEE, Sept. 4, 2021 /PRNewswire-PRWeb/ — The Hematology/Oncology Pharmacy Affiliation (HOPA) collaborated with the Nationwide Group Oncology Allotting Affiliation, Inc. (NCODA), Oncology Nursing Society (ONS), and Affiliation of Group Most cancers Facilities (ACCC) to launch a brand new Intravenous Most cancers Therapy Schooling (IVE) web site, ivcanceredsheets.com. Oncology pharmacists are inspired to make use of the schooling sheets in discussions with these present process most cancers therapy and their caregivers.
The web site is a joint effort devoted to being forward-thinking and offering thorough schooling sources to enhance therapy outcomes. The Intravenous Most cancers Therapy Schooling web site gives healthcare employees the newest schooling materials for intravenous most cancers remedies, speaking important data to assist caregivers and people experiencing most cancers.
The sheets embrace frequent makes use of and therapy schedules, supportive medicines, drug interactions, aspect impact administration, and secure dealing with ideas at dwelling following therapy. Oncology professionals and caregivers can obtain a number of IVE sheets from the location’s library, which is able to proceed to be up to date by the collaborative. The sheets are also editable so pharmacists can customise them to a person’s therapy plan.
The launch of IV Most cancers Therapy Schooling Sheets on-line follows the success of the extremely utilized OCE (Oral Chemotherapy Schooling) on-line useful resource, which is also a collaborative initiative between NCODA, HOPA, ONS, and ACCC. With a committee consisting of representatives from every of the organizations, a improvement course of is structured to supply trusted and dependable schooling sheets that present a sturdy quantity of knowledge on particular person medication and mixture drug regimens.
The Hematology/Oncology Pharmacy Affiliation (HOPA) helps hematology/oncology pharmacy professionals and promotes the function of the pharmacist in collaborative most cancers care. Based in 2004, HOPA gives essential schooling, networking, and development alternatives ceaselessly sought by pharmacists, pharmacy interns, residents, fellows, college students, technicians, researchers, and directors who specialise in hematology/oncology pharmacy. Its imaginative and prescient is to make sure that all people affected by most cancers have a hematology/oncology pharmacist as an integral member of their care group.
Michelle Sieg, HOPA, 2625731085, [email protected]oparx.org